Home News Bulk Drug

Bulk Drug

AstraZeneca bags another cancer drug deal, this time with Inovio

London, August 2015 AstraZeneca has clinched its third deal in less than a week to bolster its strategically important cancer drug pipeline by signing up rights to an experimental immune system-boosting medicine from Inovio Pharmaceuticals. Inovio will get $27.5 million upfront...

Cadila Healthcare recalls anti-hypertension drug in US

Washington- Drug firm Cadila Healthcare is voluntarily recalling 5,400 bottles of anti-hypertension drug Atenolol tablets, in the U.S. for failing to meet specifications. According to a notification by the US Food and Drug Administration (USFDA), the recall of the 5,400 bottles...

GSK-Dr Reddy’s to file for joint drug this year

Hyderabad February 19, 2014:- The first drug being jointly developed by GlaxoSmithKline (GSK) and Dr Reddy’s Laboratories will be filed for registration in this year. Speaking to newspersons on the sidelines of the ongoing BioAsia 2014 here on Tuesday,...

ANTI-ALLERGIC DRUGS RECALLED BY ZYDUS CADILA FROM US MARKET

New Delhi, June 12, 2014 - Zydus Cadila issued a voluntary recall of nearly 10,200 bottles of an anti-allergic drug from the US market. The recall was started by the company’s US unit, Zydus Pharmaceuticals USA Inc. due to...

Westernization and Industrialization in Australia to boost Drug Delivery Devices Market: Ken Research

New Delhi, December 27, 2017: Australia encouraged nanotechnology applications in various sectors such as energy, food, water, drug delivery and new ways to regenerate damaged parts of a human body such as blood vessels, brain, nerves, bone and cartilage....

NPPA fixes retail prices of 14 formulations

New Delhi, January 04, 2018: Drug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products. Drug price regulator NPPA has fixed retail prices of 14 formulations, including of those used in treatment of...

Lupin dispatches bland Tamiflu in the US

Mumbai, February 13, 2018: Pharma significant Lupin declared the dispatch of its Oseltamivir Phosphate Cases, USP having gotten an endorsement from the Unified States Nourishment and Medication Organization (FDA) prior.  

Lincoln Pharma faces ban from Tanzanian drug regulator

New Delhi, January 23, 2016: An administrative lapse turned out to be a major embarrassment for Ahmedabad-based Lincoln Pharmaceuticals Ltd, which faced cancellation of its registration with Tanzania Food and Drugs Authority (TFDA) triggering heavy sell-off in the company...

India’s dependence on imports for bulk drugs and APIs

New Delhi, May 09, 2015: As per the Boston Consulting Group Report of 2013 import of Active Pharmaceutical Ingredients (APIs) during the year 2013 was approximately US $ 3.5 billion of which a large share was from China. The...

Strides to sell Tacrolimus capsules

New Delhi, July 25, 2014 - Pharmaceutical firm Strides Arcolab has received the regulatory approval to market Tacrolimus capsules in the US market. The capsule is an immuno-suppressant used for preventing organ rejection in certain patients following liver, kidney, or...